EAT vs. RYTM
EAT (Brinker International, Inc.) and RYTM (Rhythm Pharmaceuticals, Inc.) are both stocks. EAT operates in Restaurants (Consumer Cyclical), while RYTM operates in Biotechnology (Healthcare). Over the past 5 years, EAT returned 26.98%/yr vs 38.52%/yr for RYTM. At a 0.20 correlation, their price movements are largely independent.
Performance
EAT vs. RYTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EAT achieves a 30.28% return, which is significantly higher than RYTM's -4.62% return.
EAT
- 1D
- 1.07%
- 1M
- 10.07%
- 6M
- 14.87%
- YTD
- 30.28%
- 1Y
- 22.75%
- 3Y*
- 70.46%
- 5Y*
- 26.98%
- 10Y*
- 16.29%
- ALL TIME*
- 13.10%
RYTM
- 1D
- -0.55%
- 1M
- -5.07%
- 6M
- -0.75%
- YTD
- -4.62%
- 1Y
- 16.99%
- 3Y*
- 79.24%
- 5Y*
- 38.52%
- 10Y*
- —
- ALL TIME*
- 18.33%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $195.59M | $197.14M | $174.31M | |
| $56.40M | $83.39M | $77.65M |
EAT vs. RYTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EAT Brinker International, Inc. | 30.28% | 8.49% | 206.37% | 35.32% | -12.79% | -35.32% | 36.16% | -0.92% | 17.27% | 28.77% |
RYTM Rhythm Pharmaceuticals, Inc. | -4.62% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -7.50% | 25.20% |
Correlation
The correlation between EAT and RYTM is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2017 | 0.20 |
The correlation between EAT and RYTM shifts across timeframes, from 0.07 (1 year) to 0.22 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
EAT:
$8.02B
RYTM:
$7.00B
EAT:
$10.20
RYTM:
-$3.07
EAT:
1.48
RYTM:
31.22
EAT:
20.49
RYTM:
846.77
EAT:
$5.73B
RYTM:
$217.17M
EAT:
$3.45B
RYTM:
$194.16M
EAT:
$807.20M
RYTM:
-$182.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EAT vs. RYTM — Risk / Return Rank
EAT
RYTM
EAT vs. RYTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Brinker International, Inc. (EAT) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EAT | RYTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.10 | ||
| Sortino ratioReturn per unit of downside risk | +0.17 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.10 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.60 | 0.48 | +0.12 |
| Martin ratioReturn relative to average drawdown | 1.46 | 1.08 | +0.38 |
Loading charts...
Drawdowns
EAT vs. RYTM - Drawdown Comparison
The maximum EAT drawdown since its inception was -88.40%, roughly equal to the maximum RYTM drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for EAT and RYTM.
Loading charts...
Drawdown Indicators
| EAT | RYTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.40% | -92.10% | +3.70% |
Max Drawdown (1Y)Largest decline over 1 year | -38.34% | -35.54% | -2.80% |
Max Drawdown (3Y)Largest decline over 3 years | -45.92% | -35.54% | -10.38% |
Max Drawdown (5Y)Largest decline over 5 years | -63.24% | -84.18% | +20.94% |
Max Drawdown (10Y)Largest decline over 10 years | -84.94% | — | — |
Current DrawdownCurrent decline from peak | -4.12% | -13.20% | +9.08% |
Average DrawdownAverage peak-to-trough decline | -24.28% | -31.87% | +7.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.63% | 15.72% | -0.09% |
Volatility
EAT vs. RYTM - Volatility Comparison
Brinker International, Inc. (EAT) and Rhythm Pharmaceuticals, Inc. (RYTM) have volatilities of 10.35% and 10.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EAT | RYTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.35% | 10.14% | +0.21% |
Volatility (6M)Calculated over the trailing 6-month period | 35.97% | 33.95% | +2.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.72% | 45.24% | +2.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.84% | 76.35% | -27.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 55.24% | 71.27% | -16.03% |
Dividends
EAT vs. RYTM - Dividend Comparison
Neither EAT nor RYTM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EAT Brinker International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.67% | 3.62% | 3.46% | 3.71% | 2.67% | 2.50% |
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
EAT vs. RYTM - Financials Comparison
This section allows you to compare key financial metrics between Brinker International, Inc. and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EAT vs. RYTM - Profitability Comparison
EAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Brinker International, Inc. reported a gross profit of 1.10B and revenue of 1.47B. Therefore, the gross margin over that period was 74.6%.
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
EAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Brinker International, Inc. reported an operating income of 166.60M and revenue of 1.47B, resulting in an operating margin of 11.3%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
EAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Brinker International, Inc. reported a net income of 127.90M and revenue of 1.47B, resulting in a net margin of 8.7%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
Frequently Asked Questions
EAT and RYTM have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EAT has higher volatility (10.35%) compared to RYTM (10.14%). In terms of maximum drawdown, EAT dropped -88.40% vs RYTM's -92.10%.
EAT currently has the higher Sharpe Ratio (0.48 vs 0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EAT and RYTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer